Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.
View Top Employees from Atara BiotherapeuticsWebsite | http://www.atarabio.com |
Ticker | ATRA |
Revenue | $132 million |
Funding | $302.9 million |
Employees | 509 (509 on RocketReach) |
Founded | 2012 |
Address | 2380 Conejo Spectrum St Suite 200, Thousand Oaks, California 91320, US |
Phone | (650) 278-8930 |
Technologies |
JavaScript,
HTML,
PHP
+72 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Therapeutics |
Web Rank | 1 Million |
Keywords | Solid Tumors, Hematologic Malignancies, Multiple Sclerosis |
Competitors | BioLineRx, Kite Pharma, Ocugen, Otonomy, Inc, Synergy Pharmaceuticals Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325413 Companies, NAICS Code 325414 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Atara Biotherapeutics employee's phone or email?
The Atara Biotherapeutics annual revenue was $132 million in 2024.
Eric Hyllengren is the CFO of Atara Biotherapeutics.
509 people are employed at Atara Biotherapeutics.
Atara Biotherapeutics is based in Thousand Oaks, California.
The NAICS codes for Atara Biotherapeutics are [3254, 325413, 325414, 32541, 32, 325].
The SIC codes for Atara Biotherapeutics are [283, 28].